Fact CheckerSign in

NCT07898423Completed

Association Between Polycystic Ovary Syndrome and Sleep Quality: A Questionnaire-Based Study

Source: ClinicalTrials.gov · Last updated 29 Oct 2026

Brief summary (registry, in English)

This cross-sectional study enrolled 310 women with PCOS (Rotterdam criteria) at a tertiary referral center between September 2025 and January 2026. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI); a global score \>5 defined poor sleep quality. Logistic regression and Spearman correlation analyses were performed to identify independent predictors.

Status (registry)
Completed
Study type
Observational
Enrollment
290 (actual)
First submitted
4 Oct 2026
Start date
20 Sept 2025
Primary completion date
10 Jan 2026
Lead sponsor
Tepecik Training and Research Hospital
NCT number
NCT07898423

What you commit to

  • Study type: Observational
  • Participants enrolled: 290
  • From 20 Sept 2025 to the primary completion date, 10 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previously diagnosed primary sleep disorder (e.g., obstructive sleep apnea, narcolepsy)
  • Any previously diagnosed psychiatric disorder (including depression and anxiety disorders) or current psychiatric treatment

Other illness

  • History of severe systemic disease (e.g., chronic kidney failure, liver disease)

Who the study is looking for

  • Women aged 18 to 45 years
  • Diagnosis of polycystic ovary syndrome according to the Rotterdam criteria, after exclusion of other causes of hyperandrogenism and ovulatory dysfunction (congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia and thyroid dysfunction)
  • Voluntary participation with written informed consent

Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tepecik Traning and Research Hospital
Coordinator of this site? Confirm its status
IzmirTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.